EMFACE Achieves Over 1 Million Treatments, Redefining Non-Invasive Facial Aesthetics

EMFACE: The Future of Non-Invasive Facial Treatments

In the ever-evolving landscape of facial aesthetics, BTL's EMFACE has made waves by recently surpassing 1 million treatments globally in less than two years. This milestone not only reflects the procedure's popularity but also highlights its innovative approach to facial lifting and rejuvenation. EMFACE is hailed as the fastest-growing non-invasive facial procedure that targets both the skin and the underlying muscles, providing a harmonious and youthful appearance.

The Technology Behind EMFACE

Developed by BTL, a frontrunner in medical technology, EMFACE was introduced in 2022. The procedure cleverly combines non-invasive methods to stimulate facial muscles, an achievement unprecedented in the industry. Unlike traditional solutions that rely on injectables or invasive techniques, EMFACE offers a comfortable experience with no needles, discomfort, or downtime.

Dr. Yael Halaas, a prominent facial plastic surgeon based in New York City, notes, "The ability to stimulate elevator muscles allows us to lift facial features from within—something that was never possible before with injectables or traditional energy-based devices." This innovative procedure ensures a visible lift and improved skin quality, catering to the rising demands of discerning clients seeking effective non-invasive solutions.

Expanding Horizons

The journey of EMFACE’s expansion does not stop at merely achieving high treatment numbers. Recently, BTL introduced specialized applicators for under-eye and submental areas, further enhancing the procedure's versatility. These innovations were showcased at the IMCAS World Conference held in Paris in January 2025, where they received enthusiastic feedback from medical professionals.

Dr. Kyungkook Hong from Seoul expressed the sentiment shared among many practitioners when he remarked, "EMFACE isn't just a procedure—it's a facial multiplatform that allows us to treat different areas based on each patient's unique needs. It’s a game-changer for anyone looking for natural-looking facial rejuvenation."

The Market Impact

The surge in popularity of EMFACE is attributed to its ability to complement existing injectables like Botox or fillers, offering patients a more comprehensive approach to facial aesthetics. As more practitioners adopt EMFACE into their treatment offerings, the procedure is becoming a standard for those seeking natural enhancement in their facial appearance.

Tomas Schwarz, CEO of BTL, commented on the remarkable growth, stating, "Reaching 1 million treatments in just two years is a testament to EMFACE's groundbreaking technology and the value it brings to medical professionals." BTL remains committed to integration and innovation, ensuring that EMFACE continues to evolve within the landscape of non-invasive facial treatments.

Looking to the Future

As EMFACE continues to gain traction worldwide, the company is enthusiastic about future developments. With ongoing innovations aimed at improving treatment options, the focus remains on providing effective non-invasive solutions that cater to the beauty and wellness desires of consumers. For more information regarding EMFACE and its pioneering technology, visit www.emface.com.

About BTL

BTL has established itself as a respected name in the medical equipment sector since its inception in 1993, employing over 3,000 professionals across 80 countries. The brand delivers advanced solutions for various treatments, including body shaping, skin tightening, and mental wellness, with their namesake products like EMFACE, EMSCULPT NEO, and EMSELLA standing out in the market. To explore their extensive offerings, visit www.btlaesthetics.com.